NEXGEL Postpones Third Quarter 2026 Financial Results and Corporate Update Conference Call to November 24th
LANGHORNE, Pa., Nov. 19, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive better outcomes, streamline care, and elevate the patient experience, today announced that it has postponed its conference call to discuss its financial results for the third quarter ended September 30, 2026 and provide a corporate update, which was previously scheduled for November 19, 2026, at 4:30 p.m. Eastern Time. The conference call will now be held on November 24, 2026, at 4:30 p.m. Eastern Time . The Company filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 with the Securities and Exchange Commission on November 16, 2026, which may be viewed at http://www.sec.gov/ .